The Molecular Diagnostics(MDx) market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Molecular Diagnostics(MDx) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Molecular Diagnostics(MDx) market.
Key players in the global Molecular Diagnostics(MDx) market covered in Chapter 2 and Chapter 6:
Thermo Fisher Scientific Inc
bioM?rieux SA
DiaSorin S.p.A
Luminex Corporation
geneOmbio Technologies Pvt. Ltd
MDxHealth, Inc
Danaher Corporation
TBG Diagnostics Ltd
Quidel Corporation
Savyon Diagnostics Ltd
Myriad Genetics Inc
Grifols S.A.
Biocartis NV
Amoy Diagnostics Co., Ltd
Exact Sciences Corporation
Molbio Diagnostics Pvt. Ltd
Agilent Technologies Inc
HTG Molecular Diagnostics Inc
Hologic, Inc
Abbott Laboratories
Vela Diagnostics
Genetic Signatures
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
ELITechGroup
Becton, Dickinson and Company
ABACUS Diagnostica Oy
GenMark Diagnostics Inc
Illumina Inc
QIAGEN
In Chapter 8 and Chapter 10.3, based on types, the Molecular Diagnostics(MDx) market from 2017 to 2029 is primarily split into:
Assays (Services)
Reagents & Kits
Instruments
In Chapter 9 and Chapter 10.4, based on applications, the Molecular Diagnostics(MDx) market from 2017 to 2029 covers:
Infectious Disease Diagnostics
Oncology Testing
Genetic Tests
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Molecular Diagnostics(MDx) market, containing global revenue and CAGR. The forecast and analysis of Molecular Diagnostics(MDx) market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Molecular Diagnostics(MDx). Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Molecular Diagnostics(MDx) industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Molecular Diagnostics(MDx) industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Molecular Diagnostics(MDx) in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Molecular Diagnostics(MDx) market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Molecular Diagnostics(MDx), by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Molecular Diagnostics(MDx) market, including the global sales and revenue forecast, regional forecast. It also foresees the Molecular Diagnostics(MDx) market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Molecular Diagnostics(MDx) Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics(MDx)
1.2 Molecular Diagnostics(MDx) Segment by Type
1.2.1 Global Molecular Diagnostics(MDx) Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Assays (Services)
1.2.3 The Market Profile of Reagents & Kits
1.2.4 The Market Profile of Instruments
1.3 Global Molecular Diagnostics(MDx) Segment by Application
1.3.1 Molecular Diagnostics(MDx) Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Infectious Disease Diagnostics
1.3.3 The Market Profile of Oncology Testing
1.3.4 The Market Profile of Genetic Tests
1.3.5 The Market Profile of Others
1.4 Global Molecular Diagnostics(MDx) Market, Region Wise (2017-2022)
1.4.1 Global Molecular Diagnostics(MDx) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.3 Europe Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.3.1 Germany Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.3.2 UK Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.3.3 France Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.3.4 Italy Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.3.5 Spain Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.3.6 Russia Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.3.7 Poland Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.4 China Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.5 Japan Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.6 India Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.8 Latin America Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Molecular Diagnostics(MDx) Market Status and Prospect (2017-2022)
1.5 Global Market Size of Molecular Diagnostics(MDx) (2017-2029)
1.5.1 Global Molecular Diagnostics(MDx) Revenue Status and Outlook (2017-2029)
1.5.2 Global Molecular Diagnostics(MDx) Sales Status and Outlook (2017-2029)
2 Global Molecular Diagnostics(MDx) Market Landscape by Player
2.1 Global Molecular Diagnostics(MDx) Sales and Share by Player (2017-2022)
2.2 Global Molecular Diagnostics(MDx) Revenue and Market Share by Player (2017-2022)
2.3 Global Molecular Diagnostics(MDx) Average Price by Player (2017-2022)
2.4 Global Molecular Diagnostics(MDx) Gross Margin by Player (2017-2022)
2.5 Molecular Diagnostics(MDx) Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Molecular Diagnostics(MDx) Market Competitive Situation and Trends
2.6.1 Molecular Diagnostics(MDx) Market Concentration Rate
2.6.2 Molecular Diagnostics(MDx) Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Molecular Diagnostics(MDx) Upstream and Downstream Analysis
3.1 Molecular Diagnostics(MDx) Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Molecular Diagnostics(MDx) Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Molecular Diagnostics(MDx) Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Molecular Diagnostics(MDx) Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Molecular Diagnostics(MDx)
5.3.2 Increased Demand in Emerging Markets
5.4 Molecular Diagnostics(MDx) Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Molecular Diagnostics(MDx) Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Thermo Fisher Scientific Inc
6.1.1 Thermo Fisher Scientific Inc Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Molecular Diagnostics(MDx) Product Profiles, Application and Specification
6.1.3 Thermo Fisher Scientific Inc Molecular Diagnostics(MDx) Market Performance (2017-2022)
6.1.4 Thermo Fisher Scientific Inc Business Overview
6.2 bioM